$328 Million is the total value of Tri Locum Partners LP's 47 reported holdings in Q1 2023. The portfolio turnover from Q4 2022 to Q1 2023 was 101.4% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
REGN | New | REGENERON PHARMACEUTICALS | $35,651,440 | – | 43,389 | +100.0% | 10.86% | – |
WST | Sell | WEST PHARMACEUTICAL SVSC INC | $23,154,590 | +1.3% | 66,830 | -31.2% | 7.05% | -23.7% |
ABT | New | ABBOTT LABS | $17,700,451 | – | 174,802 | +100.0% | 5.39% | – |
TNDM | New | TANDEM DIABETES CARE INC | $16,952,563 | – | 417,448 | +100.0% | 5.16% | – |
LLY | Sell | LILLY ELI & CO | $15,264,332 | -23.4% | 44,448 | -18.4% | 4.65% | -42.3% |
CTLT | New | CATALENT INC | $14,810,968 | – | 225,399 | +100.0% | 4.51% | – |
ILMN | New | ILLUMINA INC | $14,608,558 | – | 62,819 | +100.0% | 4.45% | – |
ARKK | New | ARK ETF TRunit | $14,119,000 | – | 350,000 | +100.0% | 4.30% | – |
SRPT | Sell | SAREPTA THERAPEUTICS INC | $12,261,495 | -20.9% | 88,961 | -25.7% | 3.73% | -40.5% |
AVDL | Buy | AVADEL PHARMACEUTICALS PLCsponsored adr | $12,156,209 | +148.0% | 1,327,097 | +93.9% | 3.70% | +86.8% |
MRK | Sell | MERCK & CO INC | $12,154,206 | -13.7% | 114,242 | -10.0% | 3.70% | -35.0% |
AXSM | Sell | AXSOME THERAPEUTICS INC | $9,202,964 | -40.4% | 149,205 | -25.4% | 2.80% | -55.1% |
TMO | New | THERMO FISHER SCIENTIFIC INC | $9,157,943 | – | 15,889 | +100.0% | 2.79% | – |
TEVA | New | TEVA PHARMACEUTICAL INDS LTDsponsored ads | $8,959,501 | – | 1,012,373 | +100.0% | 2.73% | – |
EVH | New | EVOLENT HEALTH INCcl a | $8,696,957 | – | 268,011 | +100.0% | 2.65% | – |
XENE | Buy | XENON PHARMACEUTICALS INC | $7,935,717 | +115.6% | 221,730 | +137.5% | 2.42% | +62.3% |
ABBV | New | ABBVIE INC | $7,843,076 | – | 49,213 | +100.0% | 2.39% | – |
BMRN | Sell | BIOMARIN PHARMACEUTICAL INC | $7,397,047 | -42.8% | 76,070 | -39.1% | 2.25% | -56.9% |
Sell | STEVANATO GROUP S P A | $7,186,395 | -30.3% | 277,467 | -51.7% | 2.19% | -47.5% | |
RETA | Sell | REATA PHARMACEUTICALS INCcl a | $6,110,370 | +13.7% | 67,206 | -52.5% | 1.86% | -14.4% |
GH | Buy | GUARDANT HEALTH INC | $5,977,458 | +68.5% | 255,011 | +95.5% | 1.82% | +26.9% |
New | VENTYX BIOSCIENCES INC | $5,120,207 | – | 152,842 | +100.0% | 1.56% | – | |
APLS | Sell | APELLIS PHARMACEUTICALS INC | $5,082,086 | -55.7% | 77,048 | -65.3% | 1.55% | -66.6% |
QURE | New | UNIQURE NV | $4,577,278 | – | 227,273 | +100.0% | 1.39% | – |
INSP | New | INSPIRE MED SYS INC | $4,101,609 | – | 17,523 | +100.0% | 1.25% | – |
Sell | ASTRIA THERAPEUTICS INC | $3,657,646 | -62.3% | 275,011 | -57.8% | 1.11% | -71.6% | |
AKRO | Sell | AKERO THERAPEUTICS INC | $3,386,928 | -52.0% | 88,524 | -31.3% | 1.03% | -63.9% |
XFOR | Buy | X4 PHARMACEUTICALS INC | $3,374,281 | -8.3% | 3,878,484 | +4.6% | 1.03% | -31.0% |
MDGL | Sell | MADRIGAL PHARMACEUTICALS INC | $3,354,090 | -56.2% | 13,845 | -47.5% | 1.02% | -67.0% |
VKTX | New | VIKING THERAPEUTICS INC | $3,330,000 | – | 200,000 | +100.0% | 1.01% | – |
BEAM | Buy | BEAM THERAPEUTICS INC | $3,283,383 | +2.3% | 107,230 | +30.7% | 1.00% | -23.0% |
PTGX | New | PROTAGONIST THERAPEUTICS INC | $3,069,396 | – | 133,452 | +100.0% | 0.94% | – |
RXDX | New | PROMETHEUS BIOSCIENCES INC | $3,055,400 | – | 28,470 | +100.0% | 0.93% | – |
ISEE | Sell | IVERIC BIO INC | $2,596,279 | -50.1% | 106,711 | -56.1% | 0.79% | -62.4% |
New | ROIVANT SCIENCES LTD | $2,542,631 | – | 344,530 | +100.0% | 0.77% | – | |
ETNB | New | 89BIO INC | $2,394,537 | – | 157,225 | +100.0% | 0.73% | – |
ALT | Buy | ALTIMMUNE INC | $2,231,595 | -58.4% | 528,814 | +62.4% | 0.68% | -68.6% |
PRAX | Buy | PRAXIS PRECISION MEDICINES I | $2,013,078 | +3431.7% | 2,488,354 | +10205.0% | 0.61% | +2565.2% |
VRNA | New | VERONA PHARMA PLCsponsored ads | $1,964,105 | – | 97,814 | +100.0% | 0.60% | – |
EOLS | New | EVOLUS INC | $1,355,876 | – | 160,269 | +100.0% | 0.41% | – |
FEMY | Buy | FEMASYS INC | $137,233 | +49.2% | 126,482 | +23.1% | 0.04% | +13.5% |
AM | Sell | ANTERO MIDSTREAM CORP | $116,586 | -28.9% | 11,114 | -26.7% | 0.04% | -45.5% |
BTG | New | B2GOLD CORP | $75,159 | – | 19,076 | +100.0% | 0.02% | – |
PGRE | New | PARAMOUNT GROUP INC | $68,436 | – | 15,008 | +100.0% | 0.02% | – |
ETRN | New | EQUITRANS MIDSTREAM CORP | $58,557 | – | 10,131 | +100.0% | 0.02% | – |
SWN | New | SOUTHWESTERN ENERGY CO | $51,785 | – | 10,357 | +100.0% | 0.02% | – |
UNIT | Sell | UNITI GROUP INC | $40,364 | -41.5% | 11,370 | -9.0% | 0.01% | -57.1% |
NLTX | Exit | NEOLEUKIN THERAPEUTICS INC | $0 | – | -10,248 | -100.0% | -0.00% | – |
MBIO | Exit | MUSTANG BIO INC | $0 | – | -33,318 | -100.0% | -0.01% | – |
OCX | Exit | ONCOCYTE CORP | $0 | – | -38,847 | -100.0% | -0.01% | – |
CRTX | Exit | QUINCE THERAPEUTICS INC | $0 | – | -22,269 | -100.0% | -0.01% | – |
Exit | LUMIRADX LTD | $0 | – | -15,621 | -100.0% | -0.01% | – | |
SYBX | Exit | SYNLOGIC INC | $0 | – | -20,961 | -100.0% | -0.01% | – |
Exit | POLARITYTE INC | $0 | – | -24,743 | -100.0% | -0.01% | – | |
BYSI | Exit | BEYONDSPRING INC | $0 | – | -10,833 | -100.0% | -0.01% | – |
OVID | Exit | OVID THERAPEUTICS INC | $0 | – | -10,009 | -100.0% | -0.01% | – |
Exit | INVIVYD INC | $0 | – | -14,967 | -100.0% | -0.01% | – | |
HBIO | Exit | HARVARD BIOSCIENCE INC | $0 | – | -10,032 | -100.0% | -0.01% | – |
PASG | Exit | PASSAGE BIO INC | $0 | – | -22,661 | -100.0% | -0.01% | – |
OMIC | Exit | SINGULAR GENOMICS SYSTEMS IN | $0 | – | -16,215 | -100.0% | -0.01% | – |
Exit | PARDES BIOSCIENCES INC | $0 | – | -19,757 | -100.0% | -0.01% | – | |
AMRX | Exit | AMNEAL PHARMACEUTICALS INC | $0 | – | -21,622 | -100.0% | -0.02% | – |
Exit | SOMALOGIC INC CLASS A | $0 | – | -16,619 | -100.0% | -0.02% | – | |
BVS | Exit | BIOVENTUS INC | $0 | – | -16,857 | -100.0% | -0.02% | – |
Exit | XERIS BIOPHARMA HOLDINGS INC | $0 | – | -36,766 | -100.0% | -0.02% | – | |
ORGO | Exit | ORGANOGENESIS HLDGS INC | $0 | – | -18,527 | -100.0% | -0.02% | – |
CRMD | Exit | CORMEDIX INC | $0 | – | -13,812 | -100.0% | -0.02% | – |
EAF | Exit | GRAFTECH INTL LTD | $0 | – | -11,869 | -100.0% | -0.02% | – |
Exit | DOUGLAS ELLIMAN INC | $0 | – | -15,785 | -100.0% | -0.03% | – | |
TCS | Exit | CONTAINER STORE GROUP INC | $0 | – | -15,026 | -100.0% | -0.03% | – |
LL | Exit | LL FLOORING HOLDINGS INC | $0 | – | -13,185 | -100.0% | -0.03% | – |
GPRO | Exit | GOPRO INCcl a | $0 | – | -16,062 | -100.0% | -0.03% | – |
LPRO | Exit | OPEN LENDING CORP | $0 | – | -12,661 | -100.0% | -0.03% | – |
STAR | Exit | ISTAR INC | $0 | – | -11,615 | -100.0% | -0.04% | – |
MTW | Exit | MANITOWOC CO INC | $0 | – | -10,358 | -100.0% | -0.04% | – |
SFL | Exit | SFL CORPORATION LTD | $0 | – | -10,702 | -100.0% | -0.04% | – |
AIV | Exit | APARTMENT INVT & MGMT COcl a | $0 | – | -14,169 | -100.0% | -0.04% | – |
HPP | Exit | HUDSON PAC PPTYS INC | $0 | – | -11,426 | -100.0% | -0.04% | – |
PDM | Exit | PIEDMONT OFFICE REALTY TR IN | $0 | – | -16,088 | -100.0% | -0.06% | – |
WU | Exit | WESTERN UN CO | $0 | – | -11,096 | -100.0% | -0.06% | – |
AHH | Exit | ARMADA HOFFLER PPTYS INC | $0 | – | -14,573 | -100.0% | -0.07% | – |
ARGX | Exit | ARGENX SEsponsored adr | $0 | – | -1,299 | -100.0% | -0.20% | – |
APLS | Exit | APELLIS PHARMACEUTICALS INCcall | $0 | – | -17,200 | -100.0% | -0.36% | – |
BMRN | Exit | BIOMARIN PHARMACEUTICAL INCcall | $0 | – | -13,100 | -100.0% | -0.55% | – |
GH | Exit | GUARDANT HEALTH INCcall | $0 | – | -62,600 | -100.0% | -0.69% | – |
PTGX | Exit | PROTAGONIST THERAPEUTICS INCcall | $0 | – | -199,500 | -100.0% | -0.88% | – |
RXDX | Exit | PROMETHEUS BIOSCIENCES INCcall | $0 | – | -25,700 | -100.0% | -1.14% | – |
RVNC | Exit | REVANCE THERAPEUTICS INCcall | $0 | – | -166,300 | -100.0% | -1.24% | – |
KZR | Exit | KEZAR LIFE SCIENCES INC | $0 | – | -473,544 | -100.0% | -1.35% | – |
TGTX | Exit | TG THERAPEUTICS INC | $0 | – | -288,462 | -100.0% | -1.38% | – |
SAVA | Exit | CASSAVA SCIENCES INCcall | $0 | – | -127,200 | -100.0% | -1.52% | – |
INMD | Exit | INMODE LTD | $0 | – | -127,242 | -100.0% | -1.84% | – |
MRTX | Exit | MIRATI THERAPEUTICS INC | $0 | – | -104,598 | -100.0% | -1.92% | – |
NVCR | Exit | NOVOCURE LTDcall | $0 | – | -72,400 | -100.0% | -2.15% | – |
PCVX | Exit | VAXCYTE INC | $0 | – | -113,477 | -100.0% | -2.20% | – |
CLDX | Exit | CELLDEX THERAPEUTICS INC NEW | $0 | – | -176,109 | -100.0% | -3.18% | – |
ASND | Exit | ASCENDIS PHARMA A/Ssponsored adr | $0 | – | -99,215 | -100.0% | -4.90% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-05-15
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
FEMASYS INC | 10 | Q3 2023 | 0.5% |
REGENERON PHARMACEUTICALS | 9 | Q3 2023 | 13.8% |
LILLY ELI & CO | 9 | Q2 2023 | 9.5% |
X4 PHARMACEUTICALS INC | 8 | Q3 2023 | 3.0% |
XENON PHARMACEUTICALS INC | 8 | Q3 2023 | 2.4% |
ARGENX SE | 7 | Q3 2023 | 12.8% |
STEVANATO GROUP S P A | 7 | Q2 2023 | 5.8% |
PROTAGONIST THERAPEUTICS INC | 7 | Q2 2023 | 7.1% |
AVADEL PHARMACEUTICALS PLC | 7 | Q3 2023 | 6.4% |
BELLUS HEALTH INC NEW | 7 | Q3 2022 | 4.3% |
View Tri Locum Partners LP's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-14 |
SC 13G/A | 2024-02-14 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-14 |
13F-HR | 2023-05-15 |
SC 13G | 2023-04-27 |
13F-HR | 2023-02-14 |
13F-HR | 2022-11-14 |
13F-HR | 2022-08-15 |
13F-HR | 2022-05-16 |
View Tri Locum Partners LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.